David A. Siegel Pulse Biosciences, Inc. Transaction History

Two Sigma Advisers, LP

  • $42.5 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.48 - $4.28 $21,161 - $61,195
-14,298 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$4.21 - $14.79 $10,525 - $36,975
-2,500 Reduced 14.88%
14,298 $69,000
Q4 2021

Feb 14, 2022
SELL
$14.78 - $24.4 $236,480 - $390,400
-16,000 Reduced 48.78%
16,798 $249,000
Q3 2021

Nov 15, 2021
SELL
$17.25 - $26.63 $62,100 - $95,868
-3,600 Reduced 9.89%
32,798 $708,000
Q2 2021

Aug 16, 2021
BUY
$16.31 - $23.64 $593,651 - $860,448
36,398 New
36,398 $597,000

Others Institutions Holding PLSE

# of Institutions
67
Shares Held
4.72M
Call Options Held
239K
Put Options Held
94.2K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $424M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email